Cargando…
Omega-3 fatty acid-based self-microemulsifying drug delivery system (SMEDDS) of pioglitazone: Optimization, in vitro and in vivo studies
Pioglitazone (PGL) is an effective insulin sensitizer, however, side effects such as accumulation of subcutaneous fat, edema, and weight gain as well as poor oral bioavailability limit its therapeutic potential for oral delivery. Recent studies have shown that combination of both, PGL and fish oil s...
Autores principales: | Emad, Nasr A., Sultana, Yasmin, Aqil, Mohd, Saleh, Asmaa, Al kamaly, Omkulthom, Nasr, Fahd A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470285/ https://www.ncbi.nlm.nih.gov/pubmed/37663396 http://dx.doi.org/10.1016/j.sjbs.2023.103778 |
Ejemplares similares
-
Self-microemulsifying drug delivery system (SMEDDS) for improved oral delivery and photostability of methotrexate
por: Kim, Dong Shik, et al.
Publicado: (2019) -
Evaluation of Carbamazepine (CBZ) Supersaturatable Self-Microemulsifying (S-SMEDDS) Formulation In-vitro and In-vivo
por: Nan, Zhang, et al.
Publicado: (2012) -
Self-microemulsifying drug delivery system (SMEDDS) of curcumin attenuates depression in olfactory bulbectomized rats
por: Aswar, Manoj, et al.
Publicado: (2020) -
Celecoxib Oral Solution and the Benefits of Self-Microemulsifying Drug Delivery Systems (SMEDDS) Technology: A Narrative Review
por: Silberstein, Stephen, et al.
Publicado: (2023) -
Effects of Spray-Drying and Choice of Solid Carriers on Concentrations of Labrasol(®) and Transcutol(®) in Solid Self-Microemulsifying Drug Delivery Systems (SMEDDS)
por: Li, Liang, et al.
Publicado: (2013)